Joshua L. Dyme

Pediatric Cardiology
349 E Northfield Rd Ste 105
Livingston,, NJ 07039

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.

Journal: The New England journal of medicine
Published: March 30, 2026

Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy.

Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy.

Journal: Journal of the American Heart Association
Published: March 20, 2026

Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.

Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.

Journal: American heart journal
Published: June 05, 2025

Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia.

Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia.

Journal: Blood advances
Published: February 11, 2025

Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.

Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.

Journal: Journal of the American College of Cardiology
Published: July 25, 2023

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.

Journal: The Lancet. Haematology
Published: May 15, 2023

Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.

Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.

Journal: Cardiology in the young
Published: December 15, 2011
Showing 1-7 of 7

Last Updated: 09/26/2026